Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis

Kidney International

Volumn 59, Issue 6, 2001, Pages 2134-2145

  Nakamura, Hiroyuki ^a,b   Isaka, Yoshitaka ^a,b   Tsujie, Michiko ^a,b   Akagi, Yoshitaka ^a,b   Sudo, Tetsuo ^a,b   Ohno, Noriko ^a,b   Imai, Enyu ^a,b   Hori, Masatsugu ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Extracellular matrix; Glomerular injury; Mesangial cell; Platelet derived growth factor; Renal failure; Skeletal muscle

Indexed keywords

COLLAGEN TYPE 1; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; ELECTROPORATION; EXTRACELLULAR MATRIX; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; KIDNEY FAILURE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM; MESANGIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SCORING SYSTEM; SKELETAL MUSCLE;

EID: 0035019610     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590062134.x     Document Type: Article

References (48)

1. Striker LJ, Peten EP, Elliot SJ, et al: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 64:446-456, 1991
2. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
3. Floege J, Johnson RJ: Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab 21:271-282, 1995
4. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 255:F674-F679, 1988
5. Iida H, Seifert R, Alpers CE, et al: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560-6564, 1991
6. Yoshimura A, Gordon K, Alpers CE, et al: Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int 40:470-476, 1991
7. Floege J. Eng E, Young BA, et al: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
8. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
9. Leveen P, Pekny M, Gebre-Medhin S, et al: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887, 1994
10. Soriano P: Abnormal kidney development and hematological disorders in PDGFβ-receptor mutant mice. Genes Dev 8:1887-1896, 1994
11. Johnson RJ, Raines EW, Floege J, et al: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
12. Floege J, Ostendorf T, Janssen U, et al: Novel approach to specific growth factor inhibition in vivo antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 154:169-179, 1999
13. Claesson WL, Eriksson A, Moren A, et al: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8:3476-3486, 1988
14. Escobedo JA, Navankasatussas S, Cousens LS, et al: A common PDGF receptor is activated by homodimeric A and B forms of PDGF. Science 240:1532-1534, 1988
15. Gronwald RG, Grant FJ, Haldeman BA, et al: Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc Natl Acad Sci USA 85:3435-3439, 1988
16. Matsui T, Heidaran M, Miki T, et al: Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243:800-804, 1989
17. Claesson WL, Eriksson A, Westermark B, Heldin CH: cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA 86:4917-4921, 1989
18. Heldin CH, Ernlund A, Rorsman C, Ronnstrand L: Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J Biol Chem 264:8905-8912, 1989
19. Frackelton AJ. Tremble PM, Williams LT: Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo: Immunopurification using a monoclonal antibody to phosphotyrosine. J Biol Chem 259:7909-7915, 1984
20. Morrison DK, Kaplan DR, Escobedo JA, et al: Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell 58:649-657, 1989
21. Kaplan DR, Morrison DK, Wong G, et al: PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 61:125-133, 1990
22. Capon DJ, Chamow SM, Mordenti J, et al: Designing CD4 immunoadhesins for AIDS therapy. Nature 337:525-531, 1989
23. Wolff JA, Ludtke JJ, Acsadi G, et al: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1:363-369, 1992
24. Wolff JA, Malone RW, Williams P, et al: Direct gene transfer into muscle in vivo. Science 247:1465-1468, 1990
25. Zimmermann U: Electric field-mediated fusion and related electrical phenomena. Biochim Biophys Acta 694:227-277, 1982
26. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841-845, 1982
27. Tsong TY: Electroporation of cell membranes. Biophys J 60:297-306, 1991
28. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867-870, 1998
29. Titomirov AV, Sukharev S, Kistanova E: In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088:131-134, 1991
30. Muramatsu T, Shibata O, Ryoki S, et al: Foreign gene expression in the mouse testis by localized in vivo gene transfer. Biochem Biophys Res Commun 233:45-49, 1997
31. Heller R, Jaroszeski M, Atkin A, et al: In vivo gene electroinjection and expression in rat liver. FEBS Lett 389:225-228, 1996
32. Rols MP, Delteil C, Golzio M, et al: In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168-171, 1998
33. Vitadello M, Schiaffino MV, Picard A, et al: Gene transfer in regenerating muscle. Hum Gene Ther 5:11-18, 1994
34. Sugiura T, Wada A, Itoh T, et al: Group II phospholipase A2 activates mitogen-activated protein kinase in cultured rat mesangial cells. FEBS Lett 370:141-145, 1995
35. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991
36. Aruffo A, Seed B: Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J 6:3313-3316, 1987
37. Fregien N, Davidson N: Activating elements in the promoter region of the chicken beta-actin gene. Gene 48:1-11, 1986
38. Merida I, Williamson P, Kuziel WA, et al: The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphati-dylinositol-3-kinase activation. J Biol Chem 268:6765-6770, 1993
39. Wolff JA, Williams P, Acsadi G, et al: Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 11:474-485, 1991
40. Schleicher E, Wieland OH: Evaluation of the Bradford method for protein determination in body fluids. J Clin Chem Clin Biochem 16:533-534, 1978
41. Isaka Y, Brees DK, Ikegaya K, et al: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2:418-423, 1996
42. Akagi Y, Isaka Y, Arai M, et al: Inhibition of TGF-β 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
43. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
44. Liu YC, Kawagishi M, Kameda R, Ohashi H: Characterization of a fusion protein composed of the extracellular domain of c-kit and the Fc region of human IgG expressed in a baculovirus system. Biochem Biophys Res Commun 197:1094-1102, 1993
45. Latta H, Fligiel S: Mesangial fenestrations, sieving, filtration, and flow. Lab Invest 52:591-598, 1985
46. Isaka Y, Akagi Y, Ando Y, et al: Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475, 1999
47. Johnson RJ, Iida H, Alpers CE, et al: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
48. Maruyama H, Sugawa M, Moriguchi Y, et al: Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum Gene Ther 11:429-437, 2000